The area review of pharmaceutical under folketrygden [the National Insurance Scheme] will create a knowledge basis for possible measures that can contribute to socio-economic efficient resource use and limit the rise in expenses for pharmaceuticals henceforward. The area review will therefore map and describe the rise in expenses and assess and suggest new or changes measures.

The contract duration is until and including 1.1.2021.

The anticipate value of the contract is from 6 000 000 NOK to 7 000 000 NOK excluding VAT. The estimate is non binding for the contracting authority.

The contracting authority reserves the right to add additional assignments in accordance with those specified in Annex 1 and that can increase the value beyond the estimate given above.

The area review of pharmaceutical under folketrygden [the National Insurance Scheme] will create a knowledge basis for possible measures that can contribute to socio-economic efficient resource use and limit the rise in expenses for pharmaceuticals henceforward. The area review will therefore map and describe the rise in expenses and assess and suggest new or changes measures.

The contract duration is until and including 1.1.2021.

The anticipate value of the contract is from 6 000 000 NOK to 7 000 000 NOK excluding VAT. The estimate is non binding for the contracting authority.

The contracting authority reserves the right to add additional assignments in accordance with those specified in Annex 1 and that can increase the value beyond the estimate given above.